ID

17836

Beskrivning

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK A 24 week double-blind, randomized, placebo-controlled, parallel-group dose-raging study to investigate the effects of rosiglitazone (extended release tablets) on cognition in subjects with mild to moderate Alzheimer´s disease. Medicine: rosiglitazone, Condition: Alzheimer´s Disease, Phase: 2, Clinical Study ID: AVA 100193, Sponsor: GSK. This ODM contains the Study Conclusion.

Nyckelord

  1. 2016-10-04 2016-10-04 -
  2. 2016-12-09 2016-12-09 -
Uppladdad den

4 oktober 2016

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK - Study Conclusion

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK - Study Conclusion

General Information
Beskrivning

General Information

Protocol Identifier: AVA100193
Beskrivning

Protocol Identifier

Datatyp

boolean

Subject Identifier
Beskrivning

Subject Identifier

Datatyp

integer

Visit Description: Study Conclusion
Beskrivning

Visit Description

Datatyp

boolean

Pregnancy Information
Beskrivning

Pregnancy Information

Did the subject become pregnant during the study?
Beskrivning

Did the subject become pregnant during the study?

Datatyp

text

Status of Treatment Blind
Beskrivning

Status of Treatment Blind

Was the treatment blind broken during the study?
Beskrivning

Was the treatment blind broken during the study?

Datatyp

text

Alias
UMLS CUI [1]
C2347038
Date blind broken
Beskrivning

Date blind broken

Datatyp

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C2347038
Reason blind broken
Beskrivning

Reason

Datatyp

text

If Other, please specify
Beskrivning

Other

Datatyp

text

Complete Non-Serious Adverse Event, Serious Adverse Event and/or Investigational Product pages, as appropriate.
Beskrivning

Complete Non-Serious Adverse Event, Serious Adverse Event and/or Investigational Product pages, as appropriate

Datatyp

boolean

Study conclusion
Beskrivning

Study conclusion

Date of subject completion or withdrawal
Beskrivning

Date of subject completion or withdrawal

Datatyp

date

Was the subject withdrawn from the study?
Beskrivning

Was the subject withdrawn from the study?

Datatyp

boolean

If yes, select the primary (!) reason for withdrawal
Beskrivning

Reason for withdrawal

Datatyp

text

If other, please specify
Beskrivning

Specification of Other

Datatyp

text

Investigator´s signature
Beskrivning

Investigator´s signature

Investigator´s signature
Beskrivning

Investigator´s signature

Datatyp

text

Investigator´s name (print)
Beskrivning

Investigator´s name (print)

Datatyp

text

Similar models

NCT00334568/ GSK-AVA100193: M.Alzheimer GSK - Study Conclusion

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
General Information
Protocol Identifier
Item
Protocol Identifier: AVA100193
boolean
Subject Identifier
Item
Subject Identifier
integer
Visit Description
Item
Visit Description: Study Conclusion
boolean
Item Group
Pregnancy Information
Item
Did the subject become pregnant during the study?
text
Code List
Did the subject become pregnant during the study?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Not applicable (not of childbearing potential or male) (3)
Item Group
Status of Treatment Blind
Item
Was the treatment blind broken during the study?
text
C2347038 (UMLS CUI [1])
Code List
Was the treatment blind broken during the study?
CL Item
No (N)
CL Item
Yes (Y)
Date blind broken
Item
Date blind broken
date
C0011008 (UMLS CUI [1,1])
C2347038 (UMLS CUI [1,2])
Item
Reason blind broken
text
Code List
Reason blind broken
CL Item
Medical emergency requiring identification of investigational product for further treatment  (1)
CL Item
Other (specify) (2)
Other
Item
If Other, please specify
text
Complete Non-Serious Adverse Event, Serious Adverse Event and/or Investigational Product pages, as appropriate
Item
Complete Non-Serious Adverse Event, Serious Adverse Event and/or Investigational Product pages, as appropriate.
boolean
Item Group
Study conclusion
Date of subject completion or withdrawal
Item
Date of subject completion or withdrawal
date
Was the subject withdrawn from the study?
Item
Was the subject withdrawn from the study?
boolean
Item
If yes, select the primary (!) reason for withdrawal
text
Code List
If yes, select the primary (!) reason for withdrawal
CL Item
Adverse event  (1)
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Sponsor terminated study (5)
CL Item
Non-compliance (6)
CL Item
Other (7)
Specification of Other
Item
If other, please specify
text
Item Group
Investigator´s signature
Investigator´s signature
Item
Investigator´s signature
text
Investigator´s name (print)
Item
Investigator´s name (print)
text

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial